Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

PubMed Links for Books (Select 1505988)

1.

In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.

Nordberg E, Orlova A, Friedman M, Tolmachev V, Ståhl S, Nilsson FY, Glimelius B, Carlsson J.

Oncol Rep. 2008 Apr;19(4):853-7.

PMID:
18357367
2.

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

Nordberg E, Friedman M, Göstring L, Adams GP, Brismar H, Nilsson FY, Ståhl S, Glimelius B, Carlsson J.

Nucl Med Biol. 2007 Aug;34(6):609-18.

PMID:
17707800
3.

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S.

Protein Eng Des Sel. 2007 Apr;20(4):189-99. Epub 2007 Apr 23.

4.

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody.

Cai W, Chen K, He L, Cao Q, Koong A, Chen X.

Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):850-8. Epub 2007 Jan 30.

PMID:
17262214
5.

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

Grünwald V, Hidalgo M.

J Natl Cancer Inst. 2003 Jun 18;95(12):851-67. Review.

6.

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.

Schechter NR, Yang DJ, Azhdarinia A, Kohanim S, Wendt R 3rd, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA.

Anticancer Drugs. 2003 Jan;14(1):49-56.

PMID:
12544258
7.

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L.

Cancer Res. 2002 Dec 15;62(24):7350-6.

8.

Biology of HER2 and its importance in breast cancer.

Yarden Y.

Oncology. 2001;61 Suppl 2:1-13. Review.

PMID:
11694782
9.

Epidermal growth factor receptor biology (IMC-C225).

Kim ES, Khuri FR, Herbst RS.

Curr Opin Oncol. 2001 Nov;13(6):506-13. Review.

PMID:
11673692
10.
11.

Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.

Wen X, Wu QP, Ke S, Ellis L, Charnsangavej C, Delpassand AS, Wallace S, Li C.

J Nucl Med. 2001 Oct;42(10):1530-7.

12.

The basic biology of HER2.

Rubin I, Yarden Y.

Ann Oncol. 2001;12 Suppl 1:S3-8. Review.

PMID:
11521719
13.

A combinatorial library of an alpha-helical bacterial receptor domain.

Nord K, Nilsson J, Nilsson B, Uhlén M, Nygren PA.

Protein Eng. 1995 Jun;8(6):601-8.

PMID:
8532685
14.

Growth factor synthesis and human breast cancer progression.

Ethier SP.

J Natl Cancer Inst. 1995 Jul 5;87(13):964-73. Review.

PMID:
7629883
15.

Predictive value of EGF receptor in breast cancer.

Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U.

Lancet. 1988 Nov 26;2(8622):1258. No abstract available.

PMID:
2903994
16.

Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E.

Cancer Res. 1988 Jan 1;48(1):137-41.

17.

Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.

Mendelsohn J.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):889-92. Review.

PMID:
2285602
18.

Epidermal growth factor.

Carpenter G, Cohen S.

J Biol Chem. 1990 May 15;265(14):7709-12. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk